Related Experiment Video
Updated: Jun 25, 2026
09:55
Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology
Published on: September 28, 2022
Leveling Up: Harnessing Cutting-Edge Technology to Enhance Oncology Education and Learning
Eleonora Teplinsky1, Tae Hoon Kim1, Stephanie Haddad2
1Valley Health System, Icahn School of Medicine at Mount Sinai, Paramus, NJ.
Summary
Digital media, gamified learning, and artificial intelligence (AI) are revolutionizing oncology education by improving knowledge sharing and engagement. Learners must critically evaluate these tools to navigate challenges like misinformation.
Area of Science:
- Oncology Education
- Medical Learning Technologies
Background:
- Digital media, gamified learning, and AI are reshaping oncology education.
- These technologies offer enhanced knowledge dissemination, networking, and professional development.
Purpose of the Study:
- To examine the transformative impact of digital media, gamification, and AI in oncology education.
- To address the challenges and risks associated with these emerging technologies.
Main Methods:
- Review of current literature on digital media, gamification, and AI in medical education.
- Analysis of the benefits and drawbacks of these technologies in oncology learning.
Main Results:
- Digital formats provide flexible learning and access to research.
- Gamification enhances critical thinking and engagement.
- AI offers personalized learning pathways and novel assessment methods.
Conclusions:
- Emerging technologies significantly enhance oncology education.
- Learners need critical appraisal skills to navigate misinformation and competition.
- Responsible use of AI and digital tools is crucial for professional development.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...